Results 101 to 110 of about 5,053,017 (341)

Test Agents: Adaptive, Autonomous and Intelligent Test Cases [PDF]

open access: yesarXiv, 2018
Growth of software size, lack of resources to perform regression testing, and failure to detect bugs faster have seen increased reliance on continuous integration and test automation. Even with greater hardware and software resources dedicated to test automation, software testing is faced with enormous challenges, resulting in increased dependence on ...
arxiv  

A comparative study of circulating tumor cell isolation and enumeration technologies in lung cancer

open access: yesMolecular Oncology, EarlyView.
Lung cancer cells were spiked into donor blood to evaluate the recovery rates of the following circulating tumor cell (CTC) enrichment technologies: CellMag™, EasySep™, RosetteSep™, Parsortix® PR1, and Parsortix® Prototype systems. Each method's advantages and disadvantages are described.
Volga M Saini   +11 more
wiley   +1 more source

Coagulation testing in the perioperative period

open access: yesIndian Journal of Anaesthesia, 2014
Perioperative coagulation management is a complex task that has a significant impact on the perioperative journey of patients. Anaesthesia providers play a critical role in the decision-making on transfusion and/or haemostatic therapy in the surgical ...
Venkatesan Thiruvenkatarajan   +2 more
doaj   +1 more source

Cell‐free and extracellular vesicle microRNAs with clinical utility for solid tumors

open access: yesMolecular Oncology, EarlyView.
Cell‐free microRNAs (cfmiRs) are small‐RNA circulating molecules detectable in almost all body biofluids. Innovative technologies have improved the application of cfmiRs to oncology, with a focus on clinical needs for different solid tumors, but with emphasis on diagnosis, prognosis, cancer recurrence, as well as treatment monitoring.
Yoshinori Hayashi   +6 more
wiley   +1 more source

KRAS and GNAS mutations in cell‐free DNA and in circulating epithelial cells in patients with intraductal papillary mucinous neoplasms—an observational pilot study

open access: yesMolecular Oncology, EarlyView.
This study demonstrates that KRAS and GNAS mutations are more prevalent in patients with resected intraductal papillary mucinous neoplasms (IPMN) compared to those under clinical surveillance. GNAS mutations significantly differ between the two patient cohorts, indicating that their absence may serve as a potential biomarker to support conservative ...
Christine Nitschke   +12 more
wiley   +1 more source

DIFFERENCES BETWEEN YOUNG (13-14 YEARS OF AGE) WATER POLO PLAYERS SELECTED AND NOT SELECTED TO THE NATIONAL TEAM [PDF]

open access: yesSport Mont, 2010
Young water polo players at age 13 to 14 years were examined once a year in a four- year period using three morphological and eight specific skill tests: body height and mass, vital capacity, swimming at distances 5, 25 and 200 meters, swimming 4x5 ...
Igor Štirn
doaj  

Understanding and Reusing Test Suites Across Database Systems [PDF]

open access: yes
Database Management System (DBMS) developers have implemented extensive test suites to test their DBMSs. For example, the SQLite test suites contain over 92 million lines of code. Despite these extensive efforts, test suites are not systematically reused across DBMSs, leading to wasted effort. Integration is challenging, as test suites use various test
arxiv   +1 more source

On‐treatment dynamics of circulating extracellular vesicles in the first‐line setting of patients with advanced non‐small cell lung cancer: the LEXOVE prospective study

open access: yesMolecular Oncology, EarlyView.
The LEXOVE prospective study evaluated plasma cell‐free extracellular vesicle (cfEV) dynamics using Bradford assay and dynamic light scattering in metastatic non‐small cell lung cancer patients undergoing first‐line treatments, correlating a ∆cfEV < 20% with improved median progression‐free survival in responders versus non‐responders.
Valerio Gristina   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy